HU211505A9
|
|
Vaccine composition for the treatment of hiv infections
|
AU2517895A
|
|
Hiv polyprotein immunogens
|
AU2517995A
|
|
Immunogenic carcinoembryonic antigen and methods of use and production
|
LV10497A
|
|
Process for the production of a vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type i
|
LV10495A
|
|
Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells
|
LV10496A
|
|
Polypeptide derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells
|
LV10492A
|
|
Vaccine and treatment method for human immunodeficiency virus
|
HRP921484A2
|
|
Vaccine and treatment method of human immunodeficiency virus infection
|
SI9200420A
|
|
Vaccine and treatment method for human immunodeficiency virus
|
BR9205290A
|
|
Vacine and method for treating human immunodeficiency virus infection
|
IL102092D0
|
|
Use of recombinant hiv envelope protein in medicament for treating hiv and therapeutic composition containing the agglomerated protein
|
WO9102819A1
|
|
Recombinant japanese encephalitis molecules and methods of use therefor
|
IL93599D0
|
|
Kit and/or composition for the prevention or treatment of aids
|
CA2003300A1
|
|
Skin test and test kit for aids
|
AU2992489A
|
|
Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
|
IL89118D0
|
|
Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
|
IL85149D0
|
|
Hiv gp160 aids virus envelope protein-containing substrates and methods for detection of aids antibody thereby
|
RO100380B1
|
|
Method for inducing aids virus coat protein production
|
RO99208B1
|
|
PROCESS FOR PRODUCING THE HEPATITIS B SURFACE ANTIGEN (HBsAg) AND THE VACCINIA VIRUS GROWTH FACTOR (VGF)
|
IE863325L
|
|
Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
|